Should Passive Income Investors Buy Clorox Stock? | CLX Stock
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 24 Aug 2026, 15:45 UTC
- Recorded by Tahlil Plus
- 24 Aug 2026, 16:30 UTC
AI-generated source summary
The analysis of Clorox (CLX) reveals a stock trading below its intrinsic value, with a forward P/E ratio of 17.07, significantly lower than its historical trading range of 16%-20% before the pandemic. The company experienced a substantial surge in revenue and operating margins during the pandemic due to increased demand for its products. However, as the economy reopened, demand and margins declined, and the company struggled to maintain its previous growth trajectory and manage cost structures effectively. The current operating margin has fallen to 13.21%, below its historical norm. Despite these challenges, the intrinsic value per share is estimated at $141, suggesting a potential upside of approximately 33% from the current market price of $106.41. The analysis indicates that investors may find an opportunity to dollar-cost average into CLX throughout the remainder of the fiscal year, as the stock is likely to continue operating under macroeconomic headwinds but could recover if it manages its cost structure and supply chain issues effectively.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.